These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6638059)

  • 1. Familial central diabetes insipidus: vasopressin and nicotine stimulated neurophysin deficiency with subnormal oxytocin and estrogen stimulated neurophysin.
    Blackett PR; Seif SM; Altmiller DH; Robinson AG
    Am J Med Sci; 1983; 286(3):42-6. PubMed ID: 6638059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Neurophysins in familial central diabetes insipidus.
    Legros JJ; Crabbe J
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1065-72. PubMed ID: 263336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes insipidus and pregnancy.
    Rubens R; Thiery M
    Eur J Obstet Gynecol Reprod Biol; 1987 Nov; 26(3):265-70. PubMed ID: 3428473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus].
    Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F
    Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous vasopressin modulates activity of oxytocin neurons in homozygous Brattleboro rats.
    Cheng SW; North WG
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E556-62. PubMed ID: 3777164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
    Flück CE; Deladoëy J; Nayak S; Zeller O; Kopp P; Mullis PE
    Eur J Endocrinol; 2001 Oct; 145(4):439-44. PubMed ID: 11581002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.
    Pullan PT; Clappison BH; Johnston CI
    J Clin Endocrinol Metab; 1979 Oct; 49(4):580-7. PubMed ID: 479348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin in human plasma: correlation with neurophysin and stimulation with estrogen.
    Amico JA; Seif SM; Robinson AG
    J Clin Endocrinol Metab; 1981 May; 52(5):988-93. PubMed ID: 7228998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus.
    Heppner C; Kotzka J; Bullmann C; Krone W; Müller-Wieland D
    J Clin Endocrinol Metab; 1998 Feb; 83(2):693-6. PubMed ID: 9467595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-stimulated release of neurophysin and vasopressin in humans.
    Husain MK; Frantz AG; Ciarochi F; Robinson AG
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1113-7. PubMed ID: 1206097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of vasopressin in familial cental diabetes insipidus.
    Kaplowitz PB; D'Ercole AJ; Robertson GL
    J Pediatr; 1982 Jan; 100(1):76-81. PubMed ID: 7057320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propressophysin in human blood: a possible marker of ectopic vasopressin production.
    Yamaji T; Ishibashi M; Hori T
    J Clin Endocrinol Metab; 1984 Sep; 59(3):505-12. PubMed ID: 6086701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus.
    Mundschenk J; Rittig S; Siggaard C; Hensen J; Lehnert H
    Exp Clin Endocrinol Diabetes; 2001; 109(8):406-9. PubMed ID: 11748489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Mol Genet Metab; 1999 May; 67(1):89-92. PubMed ID: 10329029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutant vasopressin-neurophysin II gene associated with familial neurohypophyseal diabetes insipidus.
    Miyakoshi M; Kamoi K; Murase T; Sugimura Y; Oiso Y
    Endocr J; 2004 Dec; 51(6):551-6. PubMed ID: 15644573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
    Zancaner F; Griner A; Galante E
    Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress in the diagnosis and treatment of diabetes insipidus].
    Kawakami S; Honda K; Ishikawa S; Saito T
    Nihon Rinsho; 1993 Oct; 51(10):2737-41. PubMed ID: 8254949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.